Archive for November 16th, 2009

CommVault Stock & Options Alert (CVLT)

CommVault Systems, Inc. (NASDAQ: CVLT) has been trading higher all day on the Goldman Sachs analyst upgrade to ‘Buy’ this morning.   The gains are large and we are seeing some options trading as a result.  The actual share volume is active considering this company itself, but is still far short of what we would [...]

Sprinting Sprint Nextel (S)

Sprint Nextel Corp. (NYSE: S) appears to be one the largest S&P gainers this morning.  The only news was the repayment of a $1 billion loan, but real news out today causing the run-up is the Oppenheimer upgrade to OUTPERFORM from Neutral.  The price target was also raised to $6.00 from a prior $4.00 price [...]

Netlist Stays on the Map (NLST)

Netlist Inc. (NASDAQ: NLST) is rising yet again after being on a tear last week.  This stock came under attention because of its launch of Netlist’s HyperCloud memory module for servers. This morning the company said that at Supercomputing 09, it is demonstrating the world’s first 16GB 2 virtual rank double-data-rate three, registered dual in-line [...]

Dell Pre-Earnings Upgrade (DELL)

Dell Inc. (NASDAQ: DELL) is running after Goldman Sachs re-started analyst coverage on Dell at a BUY rating and a $19.00 target.  Generally speaking, these re-starts and reinitiations do not move the meter very much.  But this is also ahead of this week’s earnings report. At 8:33 AM EST we have shares up 1.3% at [...]

Citi Surging on Paulson Stake (C)

Citigroup, Inc. (NYSE: C) is trading up on the filing showing that John Paulson, the notorious short seller, now holds a stake of 300 million shares of Citi.  At 8:28 AM EST we have seen almost 15 million shares trade hands and the gain is 4.4% to $4.23 in pre-market trading.  This is double the [...]

Nabi Smoking (NABI, GSK)

Nabi Biopharmaceuticals (NASDAQ: NABI) is soaring on a report that it and GlaxoSmithKline (NYSE: GSK) have entered into an agreement for its NicVAX, a nicotine conjugate candidate vaccine for the treatment of nicotine addiction and the prevention of smoking relapse.  GSK will pay an upfront non-refundable fee of $40 million at closing to Nabi and [...]

RADVision Hit on Cisco-Tandberg (RVSN, CSCO)

RADVision Ltd. (NASDAQ: RVSN) is under pressure on fairly thin volume because it is pre-market.   As Cisco Systems (NASDAQ: CSCO) is juicing up the buyout offer to secure a Tandberg acquisition from a dissident group of minority-stake shareholders.   Tandberg is a further move to video for Cisco, yet Cisco is RADVision’s largest client for video.  [...]

Poniard Pharma Loses Its Wings (PARD)

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is getting crushed.  The company announced that its pivotal Phase 3 SPEAR trial of picoplatin in the second-line treatment of small cell lung cancer failed to meet its primary endpoint of overall survival. The analysis was based on 320 patient deaths, and it showed a hazard ratio of 0.82 with [...]